BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/24/2019 9:22:57 AM | Browse: 953 | Download: 2298
 |
Received |
|
2019-04-11 08:56 |
 |
Peer-Review Started |
|
2019-04-12 09:45 |
 |
First Decision by Editorial Office Director |
|
2019-08-01 22:07 |
 |
Return for Revision |
|
2019-08-09 01:09 |
 |
Revised |
|
2019-08-13 14:08 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2019-08-23 10:52 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2019-08-26 23:33 |
 |
Articles in Press |
|
2019-08-26 23:33 |
 |
Edit the Manuscript by Language Editor |
|
2019-08-29 02:21 |
 |
Typeset the Manuscript |
|
2019-09-23 00:45 |
 |
Publish the Manuscript Online |
|
2019-09-24 09:22 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Case Report |
| Article Title |
Multiple myeloma complicating Guillain-Barré syndrome after bortezomib therapy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yu-Ling Xu, Wei-Hua Zhao, Zhong-Yuan Tang, Zhong-Qing Li, Yuan Long, Peng Cheng and Jun Luo |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
No. 81660038 |
|
| Corresponding Author |
Jun Luo, PhD, Chief Doctor, Professor, Department of Hematology, the First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. luojungz@medmail.com.cn |
| Key Words |
Case report; Guillain-Barré syndrome; Multiple myeloma; Bortezomib; ; |
| Core Tip |
Multiple myeloma (MM) is a malignant clonal disease, which shortens the survival time. Bortezomib, a first-line drug for the treatment of MM has prolonged patient survival. Therefore, the adverse reactions have become a hot topic. We can have a better understanding of its complications and treatment through this case. |
| Publish Date |
2019-09-24 09:22 |
| Citation |
Xu YL, Zhao WH, Tang ZY, Li ZQ, Long Y, Cheng P, Luo J. Multiple myeloma complicating Guillain-Barré syndrome after bortezomib therapy: A case report. World J Clin Cases 2019; In press |
| URL |
https://www.wjgnet.com/2307-8960/full/v7/i18/2905.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v7.i18.2905 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.